Enriched Hematopoietic Stem Cell Infusion

BIOLOGICAL2 trials

Sponsors

Talaris Therapeutics Inc.

Conditions

Kidney FailureRenal Failure

Phase 1

Induction of Donor Specific Tolerance in Recipients of Live Donor Kidney Allografts by Donor Stem Cell Infusion

Talaris Therapeutics Inc.Renal Failure

Start: 2005-01-31End: 2024-12-31Updated: 2022-07-18

Phase 2

Induction of Donor Specific Tolerance in Recipients of Living Kidney Allografts by Donor FCRx Infusion

TerminatedNCT00497926

Talaris Therapeutics Inc.Kidney Failure

Start: 2008-03-31End: 2023-04-30Updated: 2023-10-11

Related Papers

HLA molecular mismatches and induced donor-specific tolerance in combined living donor kidney and hematopoietic stem cell transplantation

Frontiers in Immunology2024-03-275 citations